E-Mail
New York, May 13, 2021 - The Heilbrunn Department of Population and Family Health (HDPFH) at the Columbia University Mailman School of Public Health announced today the creation of the Jennifer Schlecht Memorial Scholarship for Sexual and Reproductive Health (SRH) Justice in Fragile Settings which will be awarded annually as part of the Jennifer Schlecht Memorial Fund, hosted by Family Planning 2030 (FP2030) at the United Nations Foundation. The Scholarship s mission is to honor Jennifer s memory and her professional accomplishments by creating a group of highly trained, passionate public health leaders, who are bound together by a shared opportunity and commitment to championing the field of SRH justice.
C-Path and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence for neonatal drug development, from real-world neonate data. This activity, funded by the FDA, is being executed through a neonatal pilot project within C-Path s International Neonatal Consortium.
E-Mail
BOSTON - During the development and progression of Alzheimer s disease, a protein called tau accumulates and spreads in the brain. Understanding the mechanisms behind tau spread and its consequences may point to new prevention and treatment strategies for Alzheimer s disease and other forms of dementia. New insights now come from research that was led by investigators at Massachusetts General Hospital (MGH) and involves an anesthetic known to affect cognitive function. The findings are published in
The scientists note that inflammation plays an important role in Alzheimer s disease, and microglia immune cells that reside in the brain are thought to be involved in this process by producing an inflammatory molecule called interleukin-6. To see if tau stimulates microglia to drive the development of Alzheimer s disease pathology, the MGH investigators and their colleagues conducted experiments with an inhaled anesthetic called sevoflurane. Their previous work showed that sev
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
E-Mail
IMAGE: Atrial fibrillation is the most commonly diagnosed arrhythmia in the world. Despite that, many women do not understand the pre-diagnosis symptoms and tend to ignore them. view more
Credit: UBCO
A UBC Okanagan researcher is urging people to learn and then heed the symptoms of Atrial Fibrillation (AF). Especially women.
Dr. Ryan Wilson, a post-doctoral fellow in the School of Nursing, says AF is the most commonly diagnosed arrhythmia (irregular heartbeat) in the world. Despite that, he says many people do not understand the pre-diagnosis symptoms and tend to ignore them. In fact, 77 per cent of the women in his most recent study had experienced symptoms for more than a year before receiving a diagnosis.